"Adolescents with moderate to severe atopic dermatitis now have five FDA-approved treatment options and several studies have suggested that upadacitinib has the earliest and highest efficacy among these."
Collection
[
|
...
]
"Adolescents with moderate to severe atopic dermatitis now have five FDA-approved treatment options and several studies have suggested that upadacitinib has the earliest and highest efficacy among these."